KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 162 filers reported holding KYMERA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $714 | -24.8% | 23,562 | 0.0% | 0.00% | -50.0% |
| Q1 2024 | $950 | +61.0% | 23,562 | +7.1% | 0.00% | +100.0% |
| Q4 2023 | $590 | +87.3% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $315 | -36.1% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $493 | -20.7% | 22,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $622 | +10.3% | 22,000 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $564 | -99.9% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $491,000 | +10.1% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $446,000 | -51.2% | 22,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $913,000 | -27.4% | 22,000 | +10.0% | 0.00% | -33.3% |
| Q4 2021 | $1,257,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,350,422 | $159,710,097 | 16.82% |
| Aquilo Capital Management, LLC | 328,743 | $9,812,979 | 9.46% |
| BVF INC/IL | 5,161,801 | $154,079,760 | 4.32% |
| Redmile Group, LLC | 1,579,275 | $47,141,359 | 2.85% |
| Deer Management Co. LLC | 415,895 | $12,414,466 | 2.55% |
| Artal Group S.A. | 3,005,610 | $89,717,459 | 2.29% |
| Baker Brothers Advisors | 5,995,928 | $178,978,451 | 2.29% |
| Avoro Capital Advisors LLC | 3,888,888 | $116,083,307 | 1.55% |
| Checkpoint Capital L.P. | 82,000 | $2,447,700 | 1.48% |
| Deep Track Capital, LP | 1,500,000 | $44,775,000 | 1.34% |